Abpro Holdings (ABPO) Current Leases (2023 - 2025)

Abpro Holdings' (ABPO) quarterly Current Leases came in at $149000.0 in Q2 2025, down 50.33% on a QoQ basis from $300000.0 in Q1 2025.

Abpro Holdings (ABPO) Current Leases (2023 - 2025) Analysis & Trends

Abpro Holdings (ABPO) has 3 years of Current Leases data on file, last reported at $149000.0 in Q2 2025.

Quarterly Current Leases changed N/A year-over-year to $149000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $149000.0 (changed N/A YoY) and the FY2024 annual result came in at $456000.0, up 250.77% from the prior year.
Current Leases retreated to $149000.0 in Q2 2025, from $300000.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $456000.0 in Q4 2024 to a low of $130000.0 in Q4 2023.
A 3-year average of $258750.0 and a median of $224500.0 in 2025 frame the typical range for Current Leases.
The widest YoY moves for Current Leases: up 250.77% in 2024, down 250.77% in 2024.
Tracing ABPO's Current Leases over 3 years: stood at $130000.0 in 2023, then soared by 250.77% to $456000.0 in 2024, then sank by 67.32% to $149000.0 in 2025.
The last three Current Leases figures came in at $149000.0 (Q2 2025), $300000.0 (Q1 2025), and $456000.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	45.93 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	6.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Abpro Holdings	1.14 Mn	1.14 Mn	-	-

Download Data